NL Regulatory – May 2017
- Medical devices – On your marks: ready?
- Completion of the disclosure programme reform
- Action for damages against anti-competitive practices: following group actions, the “distinction” of consumers
- Action against supply shortage and product traceability : parallel trading at the center of discussions
- Further clarification on importation and exportation of tissues, cells and cellular products for therapeutic use
- Compulsory transmission to the ANSM of a summary of product characteristics for implantable and class III MDs
